WVE
Wave Life Sciences Ltd
4.00$
-9.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.6% | 97.6% | 92.2% | 82.8% | 68.3% | 65.3% | 82.4% | 78.5% | 67.3% | 85.6% | 91.0% | 96.3% | |
| 35.7% | 97.5% | 91.2% | 78.4% | 59.1% | 51.8% | 66.1% | 72.7% | 60.5% | 72.9% | 85.8% | 94.3% | |
| 35.7% | 97.5% | 91.2% | 78.4% | 59.1% | 51.8% | 66.1% | 72.7% | 60.5% | 72.9% | 85.8% | 94.3% | |
| 6.8% | 0.0% | – | 0.5% | 3.4% | 7.0% | 10.7% | 0.0% | 0.0% | 7.7% | 0.4% | 0.2% | |
| 5.7% | 0.0% | 0.0% | 0.0% | – | 3.4% | 3.7% | – | – | 0.0% | – | – | |
| 43.2% | 1.7% | 5.2% | 15.0% | 13.5% | 19.2% | 10.5% | 10.8% | 11.8% | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 31.0% | 7.2% | 18.2% | 23.1% | 75.2% | 74.8% | 67.5% | 84.3% | 130.8% | 85.6% | 40.5% | 17.6% | |
| 30.0% | 2.3% | 7.4% | 10.8% | 43.9% | 41.6% | 43.3% | 31.0% | 48.9% | 67.8% | 31.5% | 14.9% | |
| 14.6% | 0.0% | 0.0% | 0.2% | 0.8% | 1.1% | 1.3% | 2.4% | 3.8% | 2.4% | 2.2% | 1.3% | |
| 4.3% | 1.7% | 3.0% | 4.2% | 4.4% | 3.2% | 4.9% | 3.5% | 11.6% | 4.7% | 4.6% | 2.5% | |
| 2.7% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 69.0% | 92.8% | 81.8% | 76.9% | 24.8% | 25.2% | 32.5% | 15.7% | -30.8% | 14.4% | 59.5% | 82.4% | |
| -540.4% | -21.2% | -54.9% | -105.9% | -114.8% | -187.6% | -244.7% | -389.1% | -660.8% | -372.7% | -318.5% | -207.7% | |
| 712.5% | 13.0% | 13.8% | 14.6% | 9.8% | 11.9% | 14.0% | 25.0% | 53.9% | 38.6% | 39.3% | 26.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.